mskcc dcis nomogram | Breast Cancer Nomogram: Ductal Carcinoma In Situ

Keyword	CPC	PCC	Volume	Score	Length of keyword
mskcc dcis nomogram	0.87	1	3488	15	19
mskcc	1.1	0.3	8675	70	5
dcis	0.2	1	7872	81	4
nomogram	1.23	0.2	100	20	8

Keyword	CPC	PCC	Volume	Score
mskcc dcis nomogram	1.67	1	6097	28
mskcc dcis risk nomogram	0.05	0.7	128	70
mskcc nomogram dcis recurrence	0.26	0.3	4020	10
mskcc breast dcis nomogram	0.54	0.3	4030	63
msk dcis recurrence risk calculator	0.48	0.9	9987	96
mskcc nomogram breast cancer	1.21	0.4	8732	73
memorial sloan kettering dcis nomogram	1.98	0.7	5644	46
sloan kettering dcis nomogram	1.2	0.6	3603	39

Search Results related to mskcc dcis nomogram on Search Engine

Breast Cancer Nomogram: Ductal Carcinoma In Situ (DCIS) …
mskcc.org

https://nomograms.mskcc.org/Breast/DuctalCarcinomaInSituRecurrencePage.aspx

WEBA Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for DCIS. This tool predicts the likelihood that a patient’s breast cancer will recur in the same breast after receiving breast-conserving surgery for ductal carcinoma in situ (DCIS).

DA: 57 PA: 37 MOZ Rank: 43

Breast Cancer Nomogram | Memorial Sloan Kettering Cancer Center
mskcc.org

https://nomograms.mskcc.org/breast/

WEBDuctal Carcinoma In Situ (DCIS) Recurrence. This tool predicts the likelihood that a patient’s breast cancer will recur in the same breast after receiving breast-conserving surgery for ductal carcinoma in situ (DCIS).

DA: 40 PA: 5 MOZ Rank: 21

Prediction Tools | Memorial Sloan Kettering Cancer Center
mskcc.org

https://www.mskcc.org/nomograms

WEBResearchers at Memorial Sloan Kettering have pioneered the use of prediction tools known as nomograms to help patients and physicians make important treatment decisions. These tools are based on information from hundreds or even thousands of people with cancer.

DA: 14 PA: 56 MOZ Rank: 94

Treatment of Ductal Carcinoma in Situ: Considerations for …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863731/

WEBClinical tools, including the Memorial Sloan Kettering Cancer Center (MSKCC) DCIS nomogram, provide LR risk estimates after BCS that appear more accurate than current genomic assays. The safety of active surveillance …

DA: 64 PA: 23 MOZ Rank: 95

A Comparison of Local Recurrence Risk Estimates After Breast …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736743/

WEBA DCIS Nomogram, integrating 10 clinicopathologic/treatment factors, and a Refined DCIS Score (RDS), incorporating a genomic assay and 3 clinicopathologic factors (Oncotype DX DCIS Score™), are available to estimate DCIS 10-year local recurrence risk (LRR). We compared these estimates.

DA: 19 PA: 98 MOZ Rank: 28

Newly Developed Prediction Tool Helps Estimate Local …
mskcc.org

https://www.mskcc.org/news-releases/newly-developed-prediction-tool-helps-estimate-local-recurrence-patients-non-invasive-breast

WEBJul 13, 2010 · This nomogram will be a valuable tool in weighing the pros and cons of various treatments.”. Today, approximately one in five new breast cancer cases will be diagnosed as DCIS, making non-invasive breast cancer the fourth most commonly diagnosed malignancy in women.

DA: 98 PA: 26 MOZ Rank: 61

What Is Ductal Carcinoma In Situ (DCIS), and How Do I Decide …
mskcc.org

https://www.mskcc.org/news/what-ductal-carcinoma-situ-dcis-and-how-do-decide-right-treatment

WEBOct 12, 2021 · DCIS refers to abnormal cells that are confined to the milk ducts. These cells have not yet spread into the surrounding normal breast tissue and cannot spread elsewhere in the body. It’s more of a precancer, or preinvasive lesion.

DA: 44 PA: 61 MOZ Rank: 80

Recurrence Risks in Patients With Ductal Memorial Sloan …
advancesradonc.org

https://www.advancesradonc.org/article/S2452-1094%2820%2930310-9/pdf

WEBMSKCC DCIS nomogram derive a risk estimate for any IBE (in situ and invasive) from historical populational data, the DCIS score assay has been validated to provide individualized risk estimates for invasive and in situ IBE, based on quantitative RNA levels from formalin-ﬁxed, parafﬁn-embedded tumor samples.

DA: 9 PA: 71 MOZ Rank: 2

Synapse - Treatment of ductal carcinoma in situ: Considerations …
mskcc.org

https://synapse.mskcc.org/synapse/works/167311

WEBClinical tools, including the Memorial Sloan Kettering Cancer Center (MSKCC) DCIS nomogram, provide LR risk estimates after BCS that appear more accurate than current genomic assays. The safety of active surveillance …

DA: 56 PA: 53 MOZ Rank: 71

Predicting Risk of Recurrence for DCIS: Do Commercially …
doximity.com

https://opmed.doximity.com/articles/predicting-risk-of-recurrence-for-dcis-do-commercially-available-genomic-assays-have-proven-added-value-over-and-above-the-mskcc-dcis-nomogram-and-if-not-why-should-we-pay-for-them

WEBDec 18, 2022 · These have been combined into a multivariable nomogram that estimates 10-year risk of recurrence (MSKCC (Memorial Sloan Kettering Cancer Center) DCIS Nomogram). It is available online and free-of-charge at www.nomograms.org. It has been validated in at least 5 independent populations in the US and worldwide.

DA: 65 PA: 50 MOZ Rank: 92